Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations
Meric-Bernstam, Funda, Lloyd, Michael W, Koc, Soner, Evrard, Yvonne A, McShane, Lisa M, Lewis, Michael T, Evans, Kurt W, Li, Dali, Rubinstein, Lawrence, Welm, Alana, Dean, 2nd, Dennis A, Srivastava, Anuj, Grover, Jeffrey W, Ha, Min J, Chen, Huiqin, Huang, Xuelin, Varadarajan, Kaushik, Wang, Jing, Roth, Jack A, Welm, Bryan, Govinden, Ramaswamy, Ding, Li, Kaochar, Salma, Mitsiades, Nicholas, Carvajal-Carmona, Luis, Herylyn, Meenhard, Davies, Michael A, Shapiro, Geoffrey I, Fields, Ryan, Trevino, Jose G, Harrell, Joshua C, Doroshow, James H, Chuang, Jeffrey H, Moscow, Jeffrey A
Published in Molecular cancer therapeutics (02.07.2024)
Published in Molecular cancer therapeutics (02.07.2024)
Get full text
Journal Article